529
Views
192
CrossRef citations to date
0
Altmetric
Review

Oxidative stress and free radicals in COPD – implications and relevance for treatment

, &
Pages 1207-1224 | Published online: 17 Oct 2014

References

  • PilgrimEDie Entdeckung der Elemente [The discovery of the elements]StuttgartMundus Verlag1950 German
  • SiesHOxidative stress: oxidants and antioxidantsExp Physiol19978222912959129943
  • AcworthINBaileyBThe Handbook of Oxidative MetabolismChelmsford (MA)ESA, Inc1996
  • LopezADMurrayCCThe global burden of disease, 1990–2020Nat Med19984124112439809543
  • LakhdarRDendenSKassabAUpdate in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphismsExp Lung Res201137636437521721950
  • RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
  • HalliwellBAntioxidants in human health and diseaseAnnu Rev Nutr19961633508839918
  • MacNeeWOxidants and COPDCurr Drug Targets Inflamm Allergy20054662764117305519
  • HanselTTBarnesPJNew drugs for exacerbations of chronic obstructive pulmonary diseaseLancet2009374969174475519716967
  • SlotIGvan den BorstBHellwigVABarreiroEScholsAMGoskerHRThe muscle oxidative regulatory response to acute exercise is not impaired in less advanced COPD despite a decreased oxidative phenotypePLoS One201492e9015024587251
  • RahmanIMorrisonDDonaldsonKMacNeeWSystemic oxidative stress in asthma, COPD, and smokersAm J Respir Crit Care Med19961544 Pt 1105510608887607
  • BarreiroEProtein carbonylation and muscle function in COPD and other conditionsMass Spectrom Rev201433321923624167039
  • LangenRCKornSHWoutersEFROS in the local and systemic pathogenesis of COPDFree Radic Biol Med200335322623512885585
  • MacNeeWWiggsBBelzbergASHoggJCThe effect of cigarette smoking on neutrophil kinetics in human lungsN Engl J Med1989321149249282779614
  • RepineJEBastALankhorstIOxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study GroupAm J Respir Crit Care Med19971562 Pt 13413579279209
  • BarnesPJChronic obstructive pulmonary diseaseN Engl J Med200034326928010911010
  • MacNeeWRahmanIOxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991605 Pt 2S58S6510556172
  • MacNeeWOxidative stress and lung inflammation in airways diseaseEur J Pharmacol200142919520711698041
  • DinhQTSuhlingHFischerABraunAWelteTInnervation of the airways in asthma bronchiale and chronic obstructive pulmonary disease (COPD)Pneumologie2011655283292 German21271508
  • WiegmanCHLiFClarkeCJA comprehensive analysis of oxidative stress in the ozone-induced lung inflammation mouse modelClin Sci (Lond)2014126642544024040961
  • DomejWFöldes-PappZFlögelEHaditschBChronic obstructive pulmonary disease and oxidative stressCurr Pharm Biotechnol20067211712316724946
  • BirbenESahinerUMSackesenCErzurumSKatayciOOxidative stress and antioxidant defenseWorld Allergy Organ J20125191923268465
  • MacNeeWTuderRMNew paradigms in the pathogenesis of chronic obstructive pulmonary diseaseProc Am Thorac Soc20096652753119741262
  • TägerMPiecykAKöhnleinTThielUAnsorgeSWelteTEvidence of a defective thiol status of alveolar macrophages from COPD patients and smokers. Chronic obstructive pulmonary diseaseFree Radic Biol Med200029111160116511121724
  • LoukidesSBakakosPKostikasKOxidative stress in patients with COPDCurr Drug Targets201112446947721194408
  • FinkelTHolbrookNJOxidants, oxidative stress and the biology of ageingNature2000408680923924711089981
  • ChurgDFPryorWAFree-radical chemistry of cigarette smoke and its toxicological implicationsEnviron Health Perspect1985641111263007083
  • VlahosRBozinovskiSGlutathione peroxidase-1 as a novel therapeutic target for COPDRedox Rep201318414214923849338
  • BehrendtCEMild and moderate-to-severe COPD in nonsmokers: distinct demographic profilesChest200512831239124416162712
  • MakJCPathogenesis of COPD. Part II. Oxidative-antioxidative imbalanceInt J Tuberc Lung Dis200812436837418371260
  • DietrichMBlockGNorkusEPSmoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakeAm J Clin Nutr200377116016612499336
  • HansdottirSMonickMMLovanNPowersLSHunninghakeGWSmoking disrupts vitamin D metabolism in the lungsAm J Respir Crit Care Med2010181Meeting AbstractsA1425
  • DimaiHPDomejWLebGLauKHBone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapniaJ Bone Miner Res200116112132214111697811
  • LeeSHLeeSHKimCHIncreased expression of vascular endothelial growth factor and hypoxia inducible factor-1a in lung tissue of patients with chronic bronchitisClin Biochem2014477–855255924463065
  • ZepedaABPessoaAJrCastilloRLFigueroaCAPulgarVMFaríasJGCellular and molecular mechanisms in the hypoxic tissue: role of HIF-1 and ROSCell Biochem Funct201331645145923760768
  • MalhotraDThimmulappaRKMercadoNDenitrosylation of HDAC2 by targeting Nrf2 restores glucocortiosteroid sensitivity in macrophages from COPD patientsJ Clin Invest2011121114289430222005302
  • LouhelainenNMyllärniemiMRahmanIKinnulaVLAirway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectivesInt J Chron Obstruct Pulmon Dis20083458560319281076
  • LinJLThomasPSCurrent perspectives of oxidative stress and its measurement in chronic obstructive pulmonary diseaseCOPD20107429130620673039
  • GerritsenWBAsinJZanenPvan den BoschJMHaasFJMarkers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patientsRespir Med2005991849015672854
  • InonuHDorukSSahinSOxidative stress levels in exhaled breath condensate associated with COPD and smokingResp Care2012573413419
  • AntczakACiebiadaMPietrasTPiotrowskiWJKurmanowskaZGórskiPExhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary diseaseArch Med Sci20128227728522662001
  • MurataKFujimotoKKitaguchiYHoriuchiTKuboKHondaTHydrogen peroxide content and pH of expired breath condensate from patients with asthma and COPDCOPD2014111818724111595
  • KostikasKPapatheodorouGPsathakisKPanagouPLoukidesSOxidative stress in expired breath condensate of patients with COPDChest200312441373138014555568
  • KoFWLauCYLeungTFWongGWLamCWHuiDSExhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary diseaseResp Med2006100630638
  • TufvessonEEkbergMBjermerLInflammatory biomarkers in sputum predict COPD exacerbationsLung201319141341623689877
  • DrozdovskyOBartaIAntusBSputum eicosanoid profiling in exacerbations of chronic obstructive pulmonary diseaseRespiration20148740841524714447
  • KinnulaVLCrapoJDSuperoxide dismutases in the lung and human lung diseasesAm J Respir Crit Care Med2003167121600161912796054
  • RahmanIvan SchadewijkAACrowtherAJ4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in the lungs of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002166449049412186826
  • MetsoTRytiläPPetersonCHaahtelaTGranulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum-processing methodsRespir Med2001951485511207017
  • BartoliMLNovelliFCostaFMalondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseasesMediators Inflamm2011201189175221772668
  • CorradiMRubinsteinIAndreoliRAldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2003167101380138612522029
  • StanojkovicIKotur-StevuljevicJMilenkovicBPulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbationResp Med2011105Suppl 1S31S37
  • Ben MoussaBSfaxiITabkaZBen SaadHRouatbiSOxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control studyLibyan J Med201492387324929061
  • AhmadAShameemMHusainQAltered oxidant-antioxidant levels in the disease prognosis of chronic obstructive pulmonary diseaseInt J Tuberc Lung Dis20131781104110923827037
  • WoŸniakAGóreckiDSzpindaMMila-KierzenkowskaCWoŸniakBOxidant-antioxidant balance in the blood of patients with chronic obstructive pulmonary disease after smoking cessationOxid Med Cell Longev2013201389707524089631
  • NadeemARajHGChhabraSKIncreased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary diseaseInflammation2005291233216502343
  • BarreiroEFermoselleCMateu-JimenezMOxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPDFree Radic Biol Med20136585987123954470
  • ParediPKharitonovSALeakDWardSCramerDBarnesPJExhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20001622 Pt 136937310934055
  • OsoataGOHanazawaTBrindicciIPeroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteineChest200913561513152019188555
  • DrostEMSwarskiKMSauledaJOxidative stress and airway inflammation in severe exacerbations of COPDThorax200560429330015790984
  • BiswasSKRahmanIEnvironmental toxicity, redox signaling and lung inflammation: the role of glutathioneMol Aspects Med2009301–2607618760298
  • ReganEAMazurWMeoniESmoking and COPD increase sputum levels of extracellular superoxide dismutaseFree Radic Biol Med201151372673221621610
  • SorheimICDeMeoDLWashoGPolymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPDCOPD20107426226820673035
  • YaoHArunachalamGHwangJWExtracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECMProc Natl Acad Sci U S A201010735155711557620713693
  • GongoraMCLobHELandmesserULoss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndromeAm J Pathol2008173491592618787098
  • RahmanIMacNeeWRole of transcription factors in inflammatory lung diseaseThorax19985376016129797762
  • LouhelainenNRytiläPHaahtelaTKinnulaVLDjukanovićRPersistence of oxidant and protease burden in the airways after smoking cessationBMC Pulm Med200992519473482
  • LouhelainenNStarkHMazurWRytiläPDjukanovicRKinnulaVLElevation of sputum matrix metalloproteinease-9 persists up to 6 months after smoking cessation: a research studyBMC Pulm Med2010101320226090
  • RahmanIPharmacological antioxidant strategies as therapeutic interventions for COPDBiochim Biophys Acta20121822571472822101076
  • MakitaHNasuharaYNagaiKCharacterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary diseaseThorax2007621193293717573447
  • BiswasSHwangJWKirkhamPARahmanIPharmacological and dietary antioxidant therapies for chronic obstructive pulmonary diseaseCurr Med Chem201320121496153022963552
  • ItoKBarnesPJCOPD as a disease of accelerated lung agingChest2009135117318019136405
  • RahmanIMacNeeWOxidative stress and regulation of glutathione in lung inflammationEur Respir J200016353455411028671
  • GrieseMRamakersJKrasseltAImprovement of alveolar glutathione and lung function but not oxidative state in cystic fibrosisAm J Respir Crit Care Med200416982282814726422
  • BlackPNMorgan-DayAMcMillanTEPoolePJYoungRPRandomized, contolled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]BMC Pulm Med200441315581425
  • RushworthGFMegsonILExisting and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefitsPharmakol Ther20141412150159
  • DekhuijzenPNvan BeurdenWJThe role for N-acetylcysteine in the management of COPDInt J Chron Obstruct Pulmon Dis2006129910618046886
  • DecramerMRutten-van MölkenMDekhuijzenPNEffects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialLancet200536594701552156015866309
  • SteyCSteurerJBachmannSMediciTCTramèrMRThe effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic reviewEur Respir J200016225326210968500
  • ZhengJPWenFQBaiCXTwice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON); a randomised, double-blind placebo-controlled trialLancet Respir Med20142318719424621680
  • RubioMLMartin-MosqueroMCOrtegaMPeces-BarbaGGonzález-MangadoNOral N-acetylcysteine attenuates elastase-induced pulmonary emphysema in ratsChest200412541500150615078764
  • GrandjeanEMBerthetPRuffmannRLeuenbergerPEfficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trialsClin Ther200022220922110743980
  • TurnerRDBothamleyGHN-acetylcysteine for COPD: the evidence remains inconclusiveLancet Respir Med201424e324717631
  • HardyJGNewmanSPKnochMLung deposition from four nebulizersRespir Med19938764614658210617
  • GillissenAJaworskaMOrthMNacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitroRespir Med19979131591689135855
  • MorettiMBottrighiPDallariRThe effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE StudyDrugs Exp Clin Res200430414315215553660
  • CazzolaMFlorianiIPageCPThe therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient dataPulm Pharmacol Ther201023213514419854285
  • ZhengJPKangJHuangSGEffect of carbocysteine on acute exacerbations of chronic obstructive pulmonary disease (PEACE-Study): a randomised placebo-controlled studyLancet200837196292013201818555912
  • CarpagnanoGERestaOFoschino-BarbaroMPExhaled interleukin-6 and 8-isoprostane in chronic obstructive pulmonary disease; effect of carbocysteine lysine salt monohydrate (SCMC-Lys)Eur J Pharmacol20045051–316917515556150
  • TatsumiKFukuchiYPEACE Study GroupCarbocisteine improves quality of life in patients with chronic obstructive pulmonary diseaseJ Am Geriatr Soc200755111884188617979906
  • AruomaOISpencerJPMahmoodNProtection against oxidative damage and cell death by the natural antioxidant ergothioneineFood Chem Toxicol199937111043105310566875
  • HuangJXuJTianLZhongLA thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxolBiochimie2014979210324103200
  • AdenugaDCaitoSYaoHNrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reductionBiochem Biophys Res Commun20104033–445245621094147
  • MilaraJNavarroAAlmudéverPLluchJMorcilloEJCortijoJOxidative stress-induced glucocorticoid resistance is prevented by dual PDE3/PDE4 inhibition in human alveolar macrophagesClin Exp Allergy201141453554621395877
  • YangYCLiiCKLinAHInduction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stressFree Radic Biol Med201151112073208121964506
  • YaoHRahmanICurrent concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary diseaseToxicol Appl Pharmacol20112542728521296096
  • FujimotoKKuboKOkadaKKobayashiTSekiguchiMSakaiAEffects of the 21-aminosteroid U-74006F on antigen induced bronchoconstriction and bronchoalveolar eosinophilia in allergic sheepEur Respir J1996910204420498902465
  • van KlaverenRJRoelantCBoogaertsMPypeJLDemedtsMNemeryBProtective effects of the lazaroid U-74389G against hyperoxia in rat type II pneumocytesPulm Pharmacol Ther199811123309802960
  • XueTWieNXinZQingyuXAngiotensin-converting enzyme-2 overexpression attenuates inflamation in rat model of chronic obstructive pulmonary diseaseInhal Toxicol2014261142224417403
  • ArtsICHollmannPCPolyphenols and disease risk in epidemiologic studiesAm J Clin Nutr200581Suppl 1317S325S15640497
  • TabakCArtsICSmitHAHeederikDKromhoutDChronic obstructive pulmonary disease and intake of catechin, flavonols, and flavones: the MORGEN StudyAm J Respir Crit Care Med20011641616411435239
  • SantusPSolaACarlucciPLipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171883884315579728
  • RuijtersEJHaenenGRWeselerARBastAThe cocoa flavanol (−)-epicatechin protects the cortisol responsePharmacol Res201479283324269961
  • KodeARajendrasozhanSCaitoSYangSRMegsonILRahmanIResveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cellsAm J Physiol Lung Cell Mol Physiol20082943L478L48818162601
  • SiedlinskiMBoerJMSmitHAPostmaDSBoezenHMDietary factors in lung function in the general population: wine and resveratrol intakeEur Respir J201239238539121852339
  • BiswasSKMcClureDJimenezLAMegsonILRahmanICurcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activityAntioxid Redox Signal200571–2324115650394
  • MejaKKRajendrasozhanSAdenugaDCurcumin restores corticosteroid function in monocytes exposed to oxidants by maintainig HDAC2Am J Respir Cell Mol Biol200839331232318421014
  • AnandPNairHBSungBDesign of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivoBiochem Pharmacol201079333033819735646
  • QuinSAlcornJFCraigoJKEpigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitmentJ Immunol201118663693370021307292
  • MalhotraDThimmulappaRKNavas-AcienADecline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1Am J Respir Crit Care Med2008178659260418556627
  • CheungLKKhorTOKongANSynergistic effect of combinations of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammationPharm Res200926122423118841446
  • GanesanSFarisANComstockATQuercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expressionRespir Res20101113120920189
  • KumarPKhannaMSrivastavaVTyagiYKRajHGRaviKEffect of quercetin supplementation on lung antioxidants after experimental influenca virus infectionExp Lung Res200531544945916019982
  • PalozzaPSimoneRCatalanoALycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF- κB nuclear binding and increase in PPARγ expressionJ Nutr Biochem201122325926820573495
  • MaritzGSMutemwaMKayigireAXTomato juice protects the lungs of the offspring of female rats exposed to nicotine during gestation and lactationPediatr Pulmonol2011461097698621520435
  • KangJXieCNagarajanSSchaussAGWuTWuXFlavonoids from acai (Euterpeoleracea Mart.) pulp and their antioxidant and anti-inflammatory activitiesFood Chem2011128115215725214342
  • BaldrickFRElbornJSWoodsideJVEffect of fruit and vegetable intake on oxidative stress and inflammation in COPD: a randomised controlled trialEur Respir J20123961377138422088966
  • HirayamaFLeeAHOuraAMoriMHiramatsuNTaniguchiHDietary intake of six minerals in relation to risk of chronic pulmonary diseaseAsia Pac J Clin Nutr201019457257721147720
  • HolickMFVitamin D deficiencyN Engl J Med2007357326628117634462
  • SundarIKHwangJWWuSSunJRahmanIDeletion of vitamin D receptor leads to a premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formationBiochem Biophys Res Commun2011406112713321300024
  • NyunoyaTMarchTHTesfaigziYSeagraveJAntioxidant diet protects against emphysema, but increases mortality in cigarette smoke-exposed miceCOPD20118536236821834692
  • AglerAHKurthTGazianoJMBuringJECassanoPARandomized vitamin E supplementation and risk of chronic lung disease in the Women’s Health StudyThorax201166432032521257986
  • BrittonJRPavordLDRichardsKADietary antioxidant vitamin intake and lung function in the general populationAm J Respir Crit Care Med19951515138313877735589
  • RahmanIKinnulaVLStrategies to decrease ongoing oxidant burden in chronic obstructive pulmonary diseaseExpert Rev Clin Pharmakol201253293309
  • DayBJFridovichICrapoJDManganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injuryArch Biochem Biophys199734722562629367533
  • YaoHArunachalamGHwangJWExtracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECMProc Natl Acad Sci U S A201010735155711557620713693
  • SharpeMAOllossonRStewartVCClarkJBOxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide-dismutase/catalase mimenticBiochem J2002366Pt 19710711994046
  • HillasGNikolakopoulouSHussainSVassilakopoulosTAntioxidants and mucolytics in COPD management: when (if ever) and in whom?Curr Drug Targets201314222523423256719
  • DuongCSeowHJBozinovskiSCrackPJAndersonGPVlahosRGlutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in miceAm J Physiol Lung Cell Mol Physiol20102993L425L43320511341
  • StefanuttiGPierroASmithVVKleinNJEatonSPeroxynitrite decomposition catalyst FeTMPyP provides partial protection against intestinal ischemia and reperfusion injury in infant ratsPediatr Res2007621434817515836
  • RahmanIMacNeeWAntioxidant pharmacological therapies for COPDCurr Opin Pharmacol201212325626522349417
  • TidenAKSjögrenTSvenssonMthioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammationJ Biol Chem201128643375783758921880720
  • ChurgASinDDWrightJLEverything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?Am J Respir Cell Mol Biol20114561111111521685155
  • BrindicciCKharitonovSAItoMNitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20101811213019797159
  • SeimetzMParajuliMPichlAInducable NOS inhibition reverses tobacco smoke induced emphysema and pulmonary hypertension in miceCell2011147229330522000010
  • MalhotraDThimmulappaRKMercadoNDenitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patientsJ Clin Invest2011121114289430222005302
  • RózanowskaMSarnaTLandEJTruscottTGFree radical scavenging properties of melanin interaction of eu- and pheo-melanin models with reducing and oxidising radicalsFree Radic Biol Med1999265–651852510218640
  • SinghAKGhoshSBasuPHaldarCDaily variation in melatonin level, antioxidant activity and general immune response of peripheral blood mononuclear cells and lymphoid tissues of Indian goat Capra hircus during summer and winterJ Exp Biol2014525467477
  • de MouraRSPiresKMSanto FerreiraTAddition of acai (Euterpe oleracea) to cigarettes has a protective effect against emphysema in miceFood Chem Toxicol201149485586321147193
  • KimSYMoonKAJoHYAnti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammationImmunol Cell Biol201290444144821709687
  • StefanskaJSarniakAWlodarczykAApocynin reduces reactive oxygen species concentrations in exhaled breath condensate in asthmaticsExp Lung Res2012382909922296407
  • de BatileJSauledaJBalcellsEAssociation between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPDJ Nutr Biochem201223781782121889886
  • MacKeeverTMLewisSACassanoPAThe relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adultsThorax200863320821417901161
  • ShiHTimminsGMonskeMEvaluation of spin trapping agents and trapping conditions for detection of cell-generated reactive oxygen speciesArch Biochem Biophys20054371596815820217
  • BachnoffNTrusMAtlasDAlleviation of oxidative stress by potent and selective thioredoxin-mimetic peptidesFree Radic Biol Med201150101355136721377525
  • BarnesPJHistone deacetylase-2 and airway diseaseTher Adv Respir Dis20093523524319812111
  • PinhoRAChiesaDMezzomoKMOxidative stress in chronic obstructive pulmonary disease patients submitted to a rehabilitation programRespir Med200710181830183517376663
  • MerckenEMHagemanGJScholsAMAkkemansMABastAWoutersEFRehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20051728994100116040783
  • KirkhamPABarnesPJOxidative stress in COPDChest2013144126627323880677
  • ZhouJJChoMHCastaldiPJHershCPSilvermanEKLairdNMHeritability of chronic obstructive pulmonary disease and related phenotypes in smokersAm J Respir Crit Care Med2013188894194723972146
  • BrebnerJAStockleyRARecent advances in α-1-antitrypsin deficiency-related lung diseaseExpert Rev Respir Med20137321322923734645
  • HershCPPharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunitiesPharmacogenomics201011223724720136362
  • BerndtALemeASShapiroSDEmerging genetics of COPDEMBO Mol Med20124111144115523090857
  • AgustiASobradilloPCelliBAddressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicineAm J Respir Crit Care Med201118391129113721169466